Search Results - "Fair, Matthew"

Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction by Lu, Jingtao, Goldsmith, Michael-Rock, Grulke, Christopher M, Chang, Daniel T, Brooks, Raina D, Leonard, Jeremy A, Phillips, Martin B, Hypes, Ethan D, Fair, Matthew J, Tornero-Velez, Rogelio, Johnson, Jeffre, Dary, Curtis C, Tan, Yu-Mei

“…Developing physiologically-based pharmacokinetic (PBPK) models for chemicals can be resource-intensive, as neither chemical-specific parameters nor in vivo…”
Get full text

A Focused Small-Molecule Screen Identifies 14 Compounds with Distinct Effects on Toxoplasma gondii by KAMAU, Edwin T, SRINIVASAN, Ananth R, BROWN, Mark J, FAIR, Matthew G, CARAHER, Erin J, BOYLE, Jon P

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Interferon-α alters host glycosylation machinery during treated HIV infection by Giron, Leila B., Colomb, Florent, Papasavvas, Emmanouil, Azzoni, Livio, Yin, Xiangfan, Fair, Matthew, Anzurez, Alitzel, Damra, Mohammad, Mounzer, Karam, Kostman, Jay R., Tebas, Pablo, O'Doherty, Una, Tateno, Hiroaki, Liu, Qin, Betts, Michael R., Montaner, Luis J., Abdel-Mohsen, Mohamed

“…A comprehensive understanding of host factors modulated by the antiviral cytokine interferon-α (IFNα) is imperative for harnessing its beneficial effects while…”
Get full text

P030 by Solomon, Michael B, Fair, Matthew G, Kessler, Angela, Mendiolina, Jennifer, Cirocco, Robert

“…Aim Our laboratory recently noticed an influx in positive allo- and auto-crossmatches presumably due to non-HLA interfering factors. We investigated the use of…”
Get full text

Antiretroviral therapy in HIV‐1‐infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation by Patro, Sean C., Azzoni, Livio, Joseph, Jocelin, Fair, Matthew G., Sierra‐Madero, Juan G., Rassool, Mohammed S., Sanne, Ian, Montaner, Luis J.

“…In advanced HIV‐1 disease, 24 weeks of ART‐mediated recovery results in reversal of activated cell‐specific monocyte subsets, with minimal recovery of soluble…”
Get full text

ADCP Observations of Currents and Suspended Sediment in the Macrotidal Gulf of Martaban, Myanmar by Harris, Courtney K., Wacht, Jacob T., Fair, Matthew J., Côté, Jessica M.

“…The Ayeyarwady and Thanlwin Rivers, which drain Myanmar, together form one of the largest point sources of freshwater and sediment to the global ocean…”
Get full text

Sa1111 IDENTIFYING INAPPROPRIATE PRESCRIBING PRACTICES OF PROTON PUMP INHIBITORS IN AN INPATIENT HOSPITAL SETTING by Jacubowsky, Amanda, Wright, Jeffrey, Zaffiri, Kathryn, Fair, Matthew, Slenker, Amy

Get full text

Pharmacist interventions in electronic drug orders entered by prescribers by Fair, Matthew A, Pane, Fred

Get full text

Sediment and terrestrial organic carbon budgets for the offshore Ayeyarwady Delta, Myanmar: Establishing a baseline for future change by Flynn, Evan R., Kuehl, Steven A., Harris, Courtney K., Fair, Matthew J.

“…Large river deltas serve as globally important archives of terrestrial and shallow marine biogeochemical signatures and because of rapid sedimentation have the…”
Get full text

No change in HIV cellular burden and lower ADCC despite increased immune activation after combined immunotherapy with peg-IFN-α2b and two broadly neutralizing antibodies in suppressed HIV+ subjects by Papasavvas, Emmanouil, Morris, Jessicamarie, Ross, Brian, Fair, Matthew, Giron, Leila, Azzoni, Livio, Abdel-Mohsen, Mohamed, Mounzer, Karam, Kostman, Jay, Tebas, Pablo, Montaner, Luis

“…Abstract Background: Pegylated interferon α2b (peg-IFN-α2b) and the broadly neutralizing antibodies (bNabs) 3BNC117 and 10-1074 were individually shown to…”
Get full text

Direct cloning of novel and specific human neutralizing anti-interferon-alpha or anti-interferon-beta antibodies by Papasavvas, Emmanouil, Lu, Lily, Fair, Matthew, Oliva, Isabela, Cassel, Joel, Majumdar, Sonali, Mounzer, Karam, Kostman, Jay, Tebas, Pablo, Bar-Or, Amit, Muthumani, Kar, Montaner, Luis

“…Abstract Background: Type I interferons (IFNs) play a pivotal role in the development of immune responses and have significant clinical importance. However,…”
Get full text

Cloning and Functional Characterization of Novel Human Neutralizing Anti-IFN-α and Anti-IFN-β Antibodies by Papasavvas, Emmanouil, Lu, Lily, Fair, Matthew, Oliva, Isabela, Cassel, Joel, Majumdar, Sonali, Mounzer, Karam, Kostman, Jay R, Tebas, Pablo, Bar-Or, Amit, Muthumani, Kar, Montaner, Luis J

“…Type I IFNs play a pivotal role in immune response modulation, yet dysregulation is implicated in various disorders. Therefore, it is crucial to develop tools…”
Get full text

Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection by Azzoni, Livio, Giron, Leila B., Vadrevu, Surya, Zhao, Ling, Lalley‐Chareczko, Linden, Hiserodt, Emily, Fair, Matthew, Lynn, Kenneth, Trooskin, Stacey, Mounzer, Karam, Abdel‐Mohsen, Mohamed, Montaner, Luis J.

“…Opioid use has negative effects on immune responses and may impair immune reconstitution in persons living with HIV (PLWH) infection undergoing antiretroviral…”
Get full text

Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption by Papasavvas, Emmanouil, Azzoni, Livio, Ross, Brian N., Fair, Matthew, Howell, Bonnie J., Hazuda, Daria J., Mounzer, Karam, Kostman, Jay R., Tebas, Pablo, Montaner, Luis J.

“…We report on the post-hoc analysis of three clinical studies (NCT01935089, NCT00594880, and NCT00051818) with chronically HIV-infected, immune-reconstituted…”
Get full text

Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons by Tebas, Pablo, Lynn, Kenn, Azzoni, Livio, Cocchella, Giorgio, Papasavvas, Emmanouil, Fair, Matthew, Karanam, Brijesh, Sharma, Paridhima, Reeves, Jacqueline D., Petropoulos, Christos J., Lalley-Chareczko, Linden, Kostman, Jay R., Short, Willian, Mounzer, Karam, Montaner, Luis J.

“…The aim of this study was to assess the susceptibility of HIV to two HIV monoclonal antibodies (bnAbs), 3BNC117 and 10-1074, in individuals with chronically…”
Get full text

Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption by Papasavvas, Emmanouil, Azzoni, Livio, Ross, Brian N., Fair, Matthew, Howell, Bonnie J., Hazuda, Daria J., Mounzer, Karam, Kostman, Jay R., Tebas, Pablo, Montaner, Luis J.

“…We report on the post-hoc analysis of three clinical studies (NCT01935089, NCT00594880 and NCT00051818) with chronically HIV-infected, immune-reconstituted…”
Get full text

Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy by Papasavvas, Emmanouil, Azzoni, Livio, Ross, Brian N, Fair, Matthew, Yuan, Zhe, Gyampoh, Kwasi, Mackiewicz, Agnieszka, Sciorillo, Amanda C, Pagliuzza, Amelie, Lada, Steven M, Wu, Guoxin, Goh, Shih Lin, Bahnck-Teets, Carolyn, Holder, Daniel J, Zuck, Paul D, Damra, Mohammad, Lynn, Kenneth M, Tebas, Pablo, Mounzer, Karam, Kostman, Jay R, Abdel-Mohsen, Mohamed, Richman, Douglas, Chomont, Nicolas, Howell, Bonnie J, Montaner, Luis J

“…Accurate characterization of the human immunodeficiency virus (HIV) reservoir is imperative to develop an effective cure. HIV was measured in antiretroviral…”
Get full text

NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects by Papasavvas, Emmanouil, Azzoni, Livio, Kossenkov, Andrew V, Dawany, Noor, Morales, Knashawn H, Fair, Matthew, Ross, Brian N, Lynn, Kenneth, Mackiewicz, Agnieszka, Mounzer, Karam, Tebas, Pablo, Jacobson, Jeffrey M, Kostman, Jay R, Showe, Louise, Montaner, Luis J

“…We previously reported that pegylated IFN-α2a (Peg-IFN-α2a) added to antiretroviral therapy (ART)-suppressed, HIV-infected subjects resulted in plasma HIV…”
Get full text

HCV modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals by GIRON, Leila B., AZZONI, Livio, YIN, Xiangfan, LYNN, Kenneth M., ROSS, Brian N., FAIR, Matthew, DAMRA, Mohammad, SCIORILLO, Amanda C., LIU, Qin, JACOBSON, Jeffrey M., MOUNZER, Karam, KOSTMAN, Jay R., ABDEL-MOHSEN, Mohamed, MONTANER, Luis J., PAPASAVVAS, Emmanouil

Get full text

Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial by Papasavvas, Emmanouil, Azzoni, Livio, Pagliuzza, Amélie, Abdel-Mohsen, Mohamed, Ross, Brian N, Fair, Matthew, Howell, Bonnie J, Hazuda, Daria J, Chomont, Nicolas, Li, Qingsheng, Mounzer, Karam, Kostman, Jay R, Tebas, Pablo, Montaner, Luis J

“…In the pilot NCT01935089 trial, we tested whether pegylated interferon alpha2b (Peg-IFN-α2b) with antiretroviral therapy (ART) was safe and could impact HIV…”
Get more information